You are here: Industry Insights > FDA

News List

Potential blockbuster AZ immunotherapy secures FDA approval pharmafile
May 03, 2017
The FDA has granted accelerated approval to AstraZeneca’s (AZ) immunotherapy therapy Imfinzi
FDA clears Roche High-Volume Immunoassay Lab Testing Solution to Support Critical Medical Treatment americanpharmaceuticalreview
May 03, 2017
Roche announced its new, high-volume testing immunoassay solution for the cobas 8000 modular analyzer series, the cobas e 801 module, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
FDA expands approved use of Bayer’s liver cancer treatment europeanpharmaceuticalreview
May 03, 2017
The US Food and Drug Administration (FDA) has expanded the approved use of Bayer‘s Stivarga (regorafinib) to include treatment of patients with hepatocellular carcinoma (HCC or liver cancer) who have been previously treated with the drug sorafenib.
FDA approves first treatment for a form of Batten disease worldpharmanews
May 02, 2017
The U.S. Food and Drug Administration approved Brineura (cerliponase alfa) as a treatment for a specific form of Batten disease.
Takeda Announces FDA Accelerated Approval of Alunbrig americanpharmaceuticalreview
May 02, 2017
Takeda Pharmaceutical announced Alunbrig has received Accelerated Approval from the U.S. Food and Drug Administration (FDA) for the treatment of patients.
Working to Raise Awareness and Reduce Health Disparities FDA
May 02, 2017
April is National Minority Health Month and this year’s theme is “Bridging Health Equity Across Communities.”
FDA Expands Approved Use of Stivarga (regorafenib) to Treat Hepatocellular Carcinoma drugs.com
April 28, 2017
The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafinib) to include treatment of patients with hepatocellular carcinoma (HCC or liver cancer) who have been previously treated with the drug sorafenib.
FDA Approves Xatmep drugs.com
April 27, 2017
Silvergate Pharmaceuticals, Inc. announced that the United States Food and Drug Administration (FDA) approved Xatmep (methotrexate) Oral Solution, the first and only FDA-approved methotrexate oral solution.
FDA condemns 14 companies selling fraudulent cancer 'cures' online pharmafile
April 27, 2017
The FDA has struck out against a wave of companies offering cancer treatments online which fraudulently...
FDA allows novel inhaled lung cancer treatment to commence clinical trials europeanpharmaceuticalreview
April 26, 2017
North Carolina based Biomarck Pharmaceuticals has received FDA allowance to begin human trials for their patented compound BIO-11006, for adults with lung cancer.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 366 367 Next page